🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
We will determine how best to manage the hepatitis C virus (HCV) epidemic i...
Status
Completed
Location
Aga Khan University
Start Date
2021-11-01
Trial ID
NCT04943588
Treatments Being Tested
Thalassemics can develop liver fibrosis because of iron overload and hepati...
Status
Completed
Location
Faculty of Medicine- Tanta University
Start Date
2015-12
Trial ID
NCT02744105
Treatments Being Tested
This research aims to evaluate the prevalence and predictors of Occult HCV ...
Status
Completed
Location
Faculty of Medicine, Alexandria University
Start Date
2021-03-01
Trial ID
NCT04719338
Treatments Being Tested
Molbio Diagnostics Ltd. (India) has developed the Truelab™ Real Time quanti...
Status
Completed
Location
Aarhus University Hospital
Start Date
2020-01-12
Trial ID
NCT04236973
Treatments Being Tested
In this study, individuals without hepatitis C infection who are on the kid...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2020-11-20
Trial ID
NCT04575896
Treatments Being Tested
The purpose of this study is to find out how many children who are infected...
Status
Completed
Location
Univ of Alabama at Birmingham - Pediatric
Start Date
TBD
Trial ID
NCT00037076
This is an open-label study to evaluate the safety and preliminary efficacy...
Status
Completed
Location
Hospital Vera Cruz S A (Campinas-SP)
Start Date
2021-03-29
Trial ID
NCT04930861
Hepatitis C virus (HCV) infection is very common in Egypt and the middle ea...
Status
Completed
Location
Faculty of Dentistry- Cairo University
Start Date
2019-12-01
Trial ID
NCT03682549
Treatments Being Tested
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths ...
Status
Unknown
Location
Egyptian Liver Hospital
Start Date
2016-01
Trial ID
NCT02507882
Treatments Being Tested